...
首页> 外文期刊>Journal of Medicinal Chemistry >Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.
【24h】

Highly selective and orally active inhibitors of type IV collagenase (MMP-9 and MMP-2): N-sulfonylamino acid derivatives.

机译:IV型胶原酶的高选择性和口服活性抑制剂(MMP-9和MMP-2):N-磺酰基氨基酸衍生物。

获取原文
获取原文并翻译 | 示例

摘要

Various N-sulfonylamino acid derivatives were synthesized and evaluated for their in vitro and in vivo activities to inhibit type IV collagenase (MMP-9 and MMP-2). When the amino acid residue and the sulfonamide moiety were modified, their inhibitory activities were greatly affected by the structure of the sulfonamide moiety. A series of aryl sulfonamide derivatives containing biaryl, tetrazole, amide, and triple bond were found to be potent and highly selective inhibitors of MMP-9 and MMP-2. In addition, these compounds were orally active in animal models of tumor growth and metastasis. These results revealed the potential of the N-sulfonylamino acid derivatives as a new type of candidate drug for the treatment of cancer.
机译:合成了各种N-磺酰基氨基酸衍生物,并评估了它们抑制IV型胶原酶(MMP-9和MMP-2)的体外和体内活性。当氨基酸残基和磺酰胺部分被修饰时,它们的抑制活性受到磺酰胺部分结构的极大影响。发现一系列含有联芳基,四唑,酰胺和三键的芳基磺酰胺衍生物是有效的且具有高选择性的MMP-9和MMP-2抑制剂。此外,这些化合物在肿瘤生长和转移的动物模型中具有口服活性。这些结果揭示了N-磺酰基氨基酸衍生物作为治疗癌症的新型候选药物的潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号